Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony E Lang

Showing results (1-10 of 815) with videos related to

Pageof 82
Sort By:
The Lancet. Neurology|December 2, 2014
In pursuit of prodromal Parkinson's diseaseAnthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2011
A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trialsAnthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society|October 30, 2013
CommentaryAnthony E Lang
Nature Medicine|November 6, 2010
Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the futureAnthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2023
Targeting α-Synuclein: A Further ViewpointAnthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society|March 7, 2003
Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look-alike?Anthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2014
Clinical heterogeneity in progressive supranuclear palsy: challenges to diagnosis, pathogenesis and future therapiesAnthony E Lang
Movement Disorders Clinical Practice|December 6, 2018
Comment on "Is it Useful to Classify PSP and CBD as Different Disorders?"Anthony E Lang
The Lancet. Neurology|November 18, 2006
Neuroprotection in Parkinson's disease: and now for something completely different?Anthony E Lang
The New England Journal of Medicine|November 14, 2003
Subthalamic stimulation for Parkinson's disease--living better electrically?Anthony E Lang
Pageof 82

Showing results (1-10 of 815) with videos related to

Sort By:
Pageof 82
The Lancet. Neurology|December 2, 2014
In pursuit of prodromal Parkinson's diseaseAnthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2011
A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trialsAnthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society|October 30, 2013
CommentaryAnthony E Lang
Nature Medicine|November 6, 2010
Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the futureAnthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2023
Targeting α-Synuclein: A Further ViewpointAnthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society|March 7, 2003
Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look-alike?Anthony E Lang
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2014
Clinical heterogeneity in progressive supranuclear palsy: challenges to diagnosis, pathogenesis and future therapiesAnthony E Lang
Movement Disorders Clinical Practice|December 6, 2018
Comment on "Is it Useful to Classify PSP and CBD as Different Disorders?"Anthony E Lang
The Lancet. Neurology|November 18, 2006
Neuroprotection in Parkinson's disease: and now for something completely different?Anthony E Lang
The New England Journal of Medicine|November 14, 2003
Subthalamic stimulation for Parkinson's disease--living better electrically?Anthony E Lang
Pageof 82